// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Results from the European Survey on Preoperative Management and Optimization Protocols for PeriHilar Cholangiocarcinoma (PHC)

F. Ratti - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Advanced biliary tract carcinoma

N/A

Nerve Fibers in the Tumor Microenvironment as a Novel Biomarker Predicting Oncological Outcome in Intrahepatic Cholangiocarcinoma

J. Bednarsch - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Advanced biliary tract carcinoma

N/A

An International Survey of the Operative Management of Gallbladder Cancer (OMEGA-S) – Global Consistency or Widespread Heterogeny?

A. Balakrishnan - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Gallbladder cancer

N/A

Outcomes of Cholecystostomy in the Management of Acute Cholecystitis in Surgically Unfit Patients: An Audit in a Large Tertiary Centre

G. Haffenden - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Management Algorithm for Bile Duct Injuries

I. Rajput - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The “Hot Gallbladder” – Still a Hot Topic

A. Moscalu - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Multi-institutional Expert Update on the Use of Laparoscopic Bile Duct Exploration in the Management of Choledocholithiasis: Lesson Learned from 3950 Procedure

V. Lopez-Lopez - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Gallbladder disease

N/A

Comparative Analysis of Liver Volumetric Assessments Using Hermes and Synapse Software Systems

K. Joshi - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Reducing the Time from Diagnosis to Treatment in Patients with Colorectal Liver Metastases

H. Ezairjawi - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Colorectal liver metastases

N/A

Pyloroduodenojejunal Intussusception Due to Hyperplastic Polyp of the Brunner Gland

H. Bari - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The Feasibility of an International HPB Tumor Board - A Pilot and Feasibility Study

M. Siriwardhane - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Coagulation Screening in Patients Admitted to the Acute Surgical Receiving Unit - Ninewells Hospital, Dundee, Scotland

D. Gunia - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Reconstruction of Calcified Hepatic Artery in the Donor Liver: A Case Report

H. Bari - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Type 1 diabetes mellitus

N/A

Spectrum of Denovo Malignancies and their Predictors after Liver Transplantation

S. Shankar - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

NASH vs. Non-NASH HCC within and Beyond Milan Criteria in Liver Transplantation for Hepatocellular Carcinoma

L. Rajendran - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Liver cancer

N/A

Post-Liver Transplant Inferior Vena Cava Stenosis in a Large Volume UK Centre

H.V. Spiers - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Biliary Complications Following Donation after Brainstem Death Liver Transplantation

M. Elshaer - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Critical Appraisal and Clinical Significance of the Variations in the Portal and Hepatic Venous Anatomy in Liver Surgery

K. Pufal - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Perceptions and Discussions on the Use of Disease-Modifying Therapies during Family Planning in Women with Multiple Sclerosis

Riley Bove - Annual Meeting of Consortium of Multiple Sclerosis Centers (CMSC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Multiple Sclerosis

glatiramer

Nabiximols Efficacy in MS Spasticity: Treatment Effects on Spasticity Numeric Rating Scale Score and Muscle Spasm Frequency in 2 Randomized Clinical Trials

Sajida Javaid - Annual Meeting of Consortium of Multiple Sclerosis Centers (CMSC) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved